in meningiomas. 7, 17, 18, 21 Peritumoral edema associated with parasagittal or parafalcine meningiomas is common, with some series showing edema in 48% of patients. 17 At times, the edema may be symptomatic and necessitate medical therapy such as steroids to lessen or relieve symptoms. However, in other cases, the edema may be seen as T2-weighted changes on MRI, but the patient may remain asymptomatic.
Following SRS, edema can worsen in a delayed fashion. Patients with symptoms may experience progression, and asymptomatic patients with edema may become symptomatic. Post-SRS edema has been noted in as many as 7%-38% of cases. 2, 8, 10, 16, 20, 22, 26 In the current study, we evaluate the risk of postradiosurgical edema in a quantitative fashion and determine the factors associated with its occurrence in patients with parasagittal or parafalcine meningiomas.
methods patient population
We reviewed a prospectively collected database approved by the University of Virginia institutional review board and identified patients with parasagittal or parafalcine meningiomas treated with Gamma Knife radiosurgery (GKRS) between 1991 and 2013. Patients who had undergone prior resection of a WHO Grade I meningioma were included in the study, while patients with a WHO Grade II or III meningioma were excluded from the current study. Patients with clinical and imaging features characteristic of a benign meningioma involving the parasagittal or parafalcine region and no history of previous cancer were also included in the study. For inclusion, the patient's GKRS dose-planning MRI study and at least 1 post-GKRS MRI study with thin slices (5 mm or less) acquired through the volume of the head must have been available to permit volumetric analysis of the tumor and the peritumoral edema. Patients with only CT imaging were excluded from the study. Table 1 summarizes the 61 patients included in the study. Forty-eight patients had 1 discrete meningioma, 10 patients had 2 discrete meningiomas, and 3 patients had 3 discrete meningiomas that were treated with GKRS. In terms of local tumor control and edema response, these tumors were analyzed separately. The mean age of the patients in the study was 59.7 years (range 18-81.6 years). The most common clinical presentations were headache in 22 cases (29%), motor deficit in 19 cases (25%), seizures in 19 cases (25%), and visual disturbances in 13 cases (17%).
tumor characteristics
Of the 77 meningiomas included for imaging analysis, 43 were parasagittal (55.8%) and 34 were parafalcine (44.2%). The median initial tumor volume was 5.6 cm 3 (range 0.3-17.5 cm ). Treatment prior to radiosurgery treatment included resection for 62 of the tumors (80.5%). Tumor attributes are detailed in Table 1 .
gamma Knife radiosurgery technique
The GKRS technique used at our institution has been previously described. 5 For the current series, radiosurgical parameters are described in Gy (range 10-20 Gy), prescribed to a median 50% isodose line (range 30%-55%) ( Table 2) .
clinical and radiographic Follow-up MRI and clinical follow-up were performed at approximately 6-month intervals for the first 2 years after GKRS with subsequent annual follow-up thereafter. All followup imaging was reviewed by both a neuroradiologist and a neurosurgeon at our institution. Because our institution is a tertiary referral center, clinical follow-up was performed through a combination of outpatient visits to our clinic and inpatient admissions to our hospital, outpatient visits from referring primary care physicians, and inpatient admissions to referring hospitals. For the 61 patients (77 tumors), the median duration of imaging follow-up was 28 months (range 6-158 months), and the median duration of clinical follow-up was 36 months (range 6-158 months).
tumor and edema volumetric assessment
The volumes of tumor and edema were determined for each imaging data set available for patients in a longitudinal fashion. Edema volume was determined from T2-weighted MRI, and the tumor volume was determined from postcontrast T1-weighted imaging. Volumes were computed by segmenting the edema and tumors on a slice-by-slice basis and numerically integrating the resulting calculated areas using the trapezoidal rule. 23 ImageJ software (National Institutes of Health) was used for contouring and volume computations. Tumor regression was defined as a reduction of the tumor volume by more than 10% of its volume at the time of GKRS. Tumor progression was defined as an increase in the tumor volume by more than 10% of the GKRS volume. A tumor was considered stable if the lesion was within ± 10% of its volume at the time of GKRS. The 10% variation for defining an unequivocal change was selected in part based upon volumetry error estimation previously performed by our group over the range of lesion volumes commonly found in single-session GKRS. 23 The edema index has been previously used to study edema response around benign and malignant tumors including meningiomas and metastases. 7, 17, 19 At each time point for which an MR image was available, the mean edema index for a tumor was computed as follows: mean edema index = (volume of peritumoral edema)/(volume of tumor).
For the purposes of this study, we defined a regression in edema as a consistent reduction in the edema index of more than 10% from its initial value at the time of GKRS. Stable edema was defined as an edema index of ± 10% of its value at the time of GKRS. Edema was classified as progressive followed by regressive for tumors that exhibited an edema index of greater than 10% of its GKRS value at any follow-up point, but eventually demonstrated a decrease in the edema index of greater than 10% of its value at the time of GKRS. Progression of edema was defined as a persistent increase in the edema index by more than 10% as seen on each of the post-GKRS MR images. Patients with no apparent T2-weighted changes surrounding the tumor were described as having no edema.
For all meningiomas included in this study, the edema index was computed until last follow-up MRI or until the time of resection if one was undertaken for tumor growth with or without edema.
statistical analysis
Descriptive statistics for all data were presented as the median and range for continuous variables and as frequency and percentages for categorical variables. Logistic regression modeling was used to analyze the prognostic factors of post-SRS brain edema and to assess odds ratios. Potential prognostic factors investigated included age, sex, tumor volume, tumor location, prior resection, venous sinus invasion, prior brain edema, margin dose, and maximum dose. Factors with a p value < 0.25 in univariate analysis were eligible to enter into multivariate analysis by forward selection. 1 Edema indexes of different follow-up points were plotted to demonstrate the quantitative changes of brain edema. Pre-SRS tumor volume and post-SRS maximal edema index were further assessed by linear regression to model the relationship between initial tumor size and consequential peritumoral edema. All statistical tests were 2-sided, and p < 0.05 was considered statistically significant. All statistical analyses were performed using SPSS (version 20.0, IBM).
results tumor control and edema
The median radiographic follow-up in this cohort of 77 meningiomas was 28 months (range 6-158 months). Using the Kaplan-Meier approach, progression-free survival at 2, 3, and 5 years was 98%, 90%, and 90%, respectively. The edema index progressed in 75% of enlarging tumors. In 25% of enlarging tumors, the edema index was stable despite an increase in tumor volume.
New or worsening edema after radiosurgery
Following GKRS, edema developed or progressed in association with 31 tumors (40%) ( Table 3) . New or worsening edema as denoted by the maximum edema index for all treated tumors peaked at 36 months after GKRS (Fig. 1) .
Of the 31 tumors with new or progressive edema, 20 tumors had a progression of the peritumoral edema followed by eventual regression of the edema at last follow-up. For tumors that demonstrated initial edema progression followed by regression, the median interval between GKRS and peak edema was 18 months (range 6-24 months). For tumors with progressive edema at last follow-up, the median interval between GKRS and peak of the edema was longer at 36 months. Of those with progressive tumor and/ or edema after GKRS, 11 tumors (14%) at last follow-up underwent a craniotomy and resection. Regression of preexisting edema occurred in 19 tumors. The preexisting edema remained stable in 18 (23%) of tumors at last follow-up. Edema was absent at the time of the GKRS and did not develop in 9 tumors (12%).
Factors related to New or worsening edema
We evaluated factors related to new or progressive edema after GKRS (Table 4) . In univariate analysis, no prior resection was related to development of new or worsening edema (p = 0.041). Also, tumors with preexisting edema were more likely to develop persistent, progressive edema following radiosurgery (p = 0.001). There was a trend toward significance in univariate analysis for tumors with a volume of more than 10 cm 3 to develop new or worsening edema (p = 0.057).
In multivariate analysis, new or worsening edema was associated with an initial tumor volume greater than 10 cm 3 (p = 0.033), absence of prior resection (p = 0.026), prior existing peritumoral edema (p = 0.001), higher radiosurgical margin dose (p = 0.016), and higher maximum dose (p = 0.048). A linear relationship was noted between initial tumor volume and maximal tumor edema index ( Fig. 2 ; p = 0.037, R 2 = 0.09). Similarly, there was a statistically significant relationship between initial edema index and maximal tumor edema index in the post-GKRS follow-up period ( Fig. 3 ; p < 0.001, R 2 = 0.46).
corticosteroid use in the post-gKrs setting
In the post-GKRS period, 16 patients were placed on a temporary course of steroids for new or worsening edema. Given the parasagittal and parafalcine location of the meningiomas in this study, the symptoms in such patients most often included headaches but occasionally included seizures or weakness. Of those, 7 patients had radiographic and clinical improvement of their edema with a short course of steroids.
discussion
Peritumoral edema occurs in 11%-92% of meningiomas at baseline. 2, 13, 18 Patients with significant mass effect and edema associated with a meningioma frequently undergo resection, but this resection may be subtotal in nature. Those meningioma patients selected for SRS may in fact be less likely to exhibit peritumoral edema than those who undergo resection. However, radiosurgery is still used at times for treating patients who exhibit peritumoral edema, particularly if it is mild or if associated symptoms are controlled with corticosteroids.
After SRS, reports of new or worsening peritumoral edema have been reported in 14%-25% of patients. 2, 3, 10, 11 This edema usually occurs in a delayed fashion after radiosurgery. In a study by Kondziolka et al., the onset of edema typically occurred 6-8 months after SRS (range 1-23 months). 12 However, in a study by Cai et al., the median time to onset of new or worsening edema was slightly earlier at 4 months, but the at-risk period was longer (range 1.5-48 months). 2 Kan et al. found that the mean time to edema was 5.5 months after SRS and the mean duration was 16 months. 10 Post-SRS edema has been associated with tumor volume, preexisting edema, tumor-brain contact area, and radiation dose. 2, 3, 10, 11 In the current study, we observed new or worsening edema in 40% of patients, of whom 26% eventually had edema regression but 14% had persistence of the edema after radiosurgery. We found that an elevated edema index frequently started 6 months post-GKRS, and the maximum edema index in our study occurred 36 months after GKRS (Fig. 1) . The time interval for onset of edema and peak of the edema represent a combination of those patients with progressive and persistent edema as well as those who have initially progressive edema followed by eventual regression of the edema and usually tumor regression as well.
In the current study, patients with a tumor volume greater than 10 cm 3 , preexisting brain edema, no prior resection, and treatment with a higher dose were more likely to experience progressive edema following radiosurgery. Others have found that radiosurgery for meningiomas exceeding 10 cm 3 have been associated with a worse prognosis after radiosurgery. 4 The current study and prior ones suggest but do not irrefutably demonstrate that resection, even if incomplete, may be of benefit to such patients if it will enable a reduction in the tumor volume below 10 cm 3 and eliminate the edema at the time of radiosurgery delivery. 4 Practically, less than one-fourth of all cases of * Regression: edema index decrease persistently > 10%; Stable: edema index decrease or increase within ± 10%; progression, then regression: edema index increase > 10% and then decrease > 10% compared to original edema index; progression: edema index increase persistently >10%; no edema: edema index = 0 during the period of SRS and follow-up. involving a parasagittal/parafalcine meningioma lead to a Simpson Grade I removal, and this is particularly the case when the tumor invades the dura of the superior sagittal sinus. 25 Although there is no definitive proof in the literature, it is interesting to consider the possibility that multisession radiosurgery for meningioma patients could afford a lower risk of new or worsening edema. In terms of radiation dose as a risk factor for edema, fractionation may offer some reduction in the risk of subsequent edema formation. 6 In one study of patients with convexity and parasagittal meningiomas, fractionated SRS was associated with less risk of posttreatment edema than SRS. 6 In another study by Unger and colleagues, the authors found that post-SRS edema for meningiomas was associated with single fraction as compared with multifraction SRS (2 or more fractions). 26 In a study evaluating edema after SRS or radiotherapy, Kalapurakal et al. demonstrated a statistically significant increase in edema when radiation was delivered in more than 6 Gy per fraction. 9 In a cohort of partially resected meningiomas treated with radiation therapy at the University of California, San Francisco, there were no cases of posttreatment edema. 1 The potential benefits of fractionation in terms of reducing postradiosurgical edema along with the alteration in the biological effective dose as it relates to tumor control will require more rigorous study.
Previous SRS studies have demonstrated a tendency for increased peritumoral edema in parafalcine and parasagittal meningiomas compared with skull base ones. 3 Such edema has been associated with postradiosurgical morbidity. 13 Peritumoral edema associated with meningiomas is likely vasogenic in nature, although some contend that a cytotoxic component contributes to the edema as well. 7, 29 Meningiomas with edema have been shown to exhibit blood vessels with hyperpermeability, and, thus, the tumor itself may be the source of at least some of the edema fluid.
24 Such a pathophysiology for the peritumoral edema would necessitate partial breakdown of the tumorbrain interface as is often seen with irregular or widened enhancement of the tumor margin on postcontrast MR images. Moreover, temporary swelling of a parasagittal or parafalcine meningioma can compress the adjacent venous structures and lead to additional cerebral edema. Ischemic changes in edematous brain parenchyma may lead to expression of vascular endothelial growth factor (VEGF). VEGF receptors have also been shown to exhibit a significantly positive relationship to edema volume. 18, 29 Combining these factors, some patients with a parafalcine or parasagittal meningioma may experience a period of worsening cerebral edema and accompanying neurological dysfunction following SRS.
Corticosteroids are most commonly used to reduce the peritumoral edema associated with meningiomas. The use of prophylactic anticonvulsants may also be considered depending upon the degree and location of the edema. VEGF inhibitors such as bevacizumab have been shown to reduce baseline peritumoral edema as well as edema following radiosurgery and radiation therapy. 14, 15 We have also reported on the use of bevacizumab for arteriovenous malformations and have used it rarely in the setting of other benign intracranial pathologies. 28 While bevacizumab was part of the current study, there is substantial reason to believe that it would be of therapeutic value for meningioma patients with worsening edema and particularly those who are intolerant of, or whose edema is refrac- tory to, corticosteroid treatment. Alternately, resection of a meningioma with worsening edema can be undertaken if necessary. However, it is rare for a meningioma treated with radiosurgery to necessitate resection for edema alone, as this edema is transient and is usually manageable with medical therapy.
study limitations
This study has limitations inherent to single-center, retrospective clinical trials. Patient selection, referral patterns from community centers to a tertiary care center, and evolving treatment algorithms have led to biases within the current study. Also, while 80.5% of patients had histological diagnosis as a WHO Grade I meningioma, the remaining patients were included on the basis of clinical and radiographic features. While a minority of the cohort, these patients without histological confirmation could have harbored tumor other than Grade I meningiomas, and, as such, introduce a study bias. In addition, the radiosurgical technique including the delivery device, dose planning software, neuroimaging protocols for stereotactic targeting, and dose selection have evolved over the study period.
We did not routinely perform MR venography or conventional angiography as part of pre-or post-GKRS assessment. Therefore, we could not evaluate this likely important factor of venous stasis or occlusion as a contributing factor to peritumoral edema. Volumetric segmentation of the tumor and edema are subject to well-known biases, particularly in the setting of smaller tumors where tomographic errors and contouring variations may lead to greater uncertainty. 23 In addition, our volumetric criteria for tumor progression, regression, and stability do vary from other systems (e.g., RECIST). 27 Also, as some patients were placed on a regimen of corticosteroids during this study, the presence of steroids could have confounded the measurements of the edema index. Further study of the phenomenon of postradiosurgical edema should be performed and is underway in a multicenter study.
conclusions
Parasagittal and parafalcine meningiomas may develop new or worsening edema following SRS. In these 2 locations, temporary or permanent T2-weighted changes after radiosurgery are not rare. Progressive edema is related to the initial volume of the tumor. While the progressive edema occurs in a minority of patients, the occurrence of such edema nevertheless warrants longitudinal clinical and radiographic follow-up of treated patients. Intervention with medications or resection may be required for symptomatic and persistent edema following radiosurgery.
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